Date | Insider | Price | Amount |
---|---|---|---|
4-26-2016 Insider Buy |
Michael Ray Costa VP, GC AND SECRETARY |
$22.00 CAGR » |
$8,140.00 370 shares |
4-26-2016 Insider Buy |
Jonathan L. Wilcox VP & CFO |
$22.00 CAGR » |
$11,000.00 500 shares |
4-26-2016 Insider Buy |
John J. McDonough EVP, COO AND TREASURER |
$22.00 CAGR » |
$22,000.00 1,000 shares |
4-26-2016 Insider Buy |
Joseph A. Carlucci CEO |
$22.00 CAGR » |
$11,000.00 500 shares |
Also See: Institutional Holders of ARA
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/27/2016 | |
End date: | 01/25/2021 | |
Start price/share: | $27.50 | |
End price/share: | $11.52 | |
Dividends collected/share: | $0.00 | |
Total return: | -58.11% | |
Average Annual Total Return: | -16.74% | |
Starting investment: | $10,000.00 | |
Ending investment: | $4,188.11 | |
Years: | 4.75 |
American Renal Associates Holdings Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent American Renal Associates Holdings insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ARA
Free ARA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |